← Back to Company DatabaseVisit Website
Guardant Health
Precision oncology through liquid biopsy technology.
PublicRedwood City, CAFounded 2012
About
Guardant Health is a leading precision oncology company that develops blood tests for cancer detection and treatment guidance. Its Guardant360 test analyzes circulating tumor DNA to help oncologists identify actionable mutations. The company also developed the Shield test for colorectal cancer screening.
Total Funding
$900MKey Product
Guardant360 CDx liquid biopsy testGeography
North AmericaKey Investors
Sequoia CapitalKhosla VenturesOrbiMed
Focus Areas
Early Detection / ScreeningDiagnosticsTreatment (Therapeutics)
Technology
Liquid BiopsyGenomics / SequencingAI / Machine Learning
Cancer Types
Pan-cancerLungColorectal
Last updated: Feb 4, 2026